Dysfunctional uterine bleeding

Australian Family Physician

Volumn 33, Issue 11, 2004, Pages 906-908

  Farrell, Elizabeth ^a  

^a Jean Hailes Foundation for Women's Health   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; GESTAGEN; TRANEXAMIC ACID;

DIFFERENTIAL DIAGNOSIS; FEMALE; GYNECOLOGIC SURGERY; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; REVIEW; UTERUS BLEEDING; UTERUS DISEASE;

ANTIFIBRINOLYTIC AGENTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; INTRAUTERINE DEVICES, MEDICATED; PROGESTINS; TRANEXAMIC ACID; UTERINE DISEASES; UTERINE HEMORRHAGE;

EID: 16644383392     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. The initial management of menorrhagia: evidence based clinical guidelines. No. 1. Royal College of Obstetricians and Gynaecologists, 1998.
2. Guidelines for the management of heavy menstrual bleeding. National Health Committee New Zealand, 1998.
3. Shankar M, Lee CA, Sabin CA, Evonomides DL, Kadir RA. Von Willebrand disease in women with menorrhagia: a systematic review. BJOG 2004;111:734-740.
4. Bongers MY, Mol BW, Brolmann HA. Current treatment of dysfunctional uterine bleeding. Maturitas 2004;47:159-174.